536 related articles for article (PubMed ID: 28501926)
21. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
[TBL] [Abstract][Full Text] [Related]
23. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR
J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765
[TBL] [Abstract][Full Text] [Related]
24. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
[TBL] [Abstract][Full Text] [Related]
25. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
[TBL] [Abstract][Full Text] [Related]
26. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
[TBL] [Abstract][Full Text] [Related]
27. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M
Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes.
Falcone M; Tiseo G; Iraci F; Raponi G; Goldoni P; Delle Rose D; Santino I; Carfagna P; Murri R; Fantoni M; Fontana C; Sanguinetti M; Farcomeni A; Antonelli G; Aceti A; Mastroianni C; Andreoni M; Cauda R; Petrosillo N; Venditti M
Clin Microbiol Infect; 2019 Apr; 25(4):474-480. PubMed ID: 29964230
[TBL] [Abstract][Full Text] [Related]
29. An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.
van Beurden YH; Dekkers OM; Bomers MK; Kaiser AM; van Houdt R; Knetsch CW; Girbes AR; Mulder CJ; Vandenbroucke-Grauls CM
PLoS One; 2016; 11(8):e0160778. PubMed ID: 27533048
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
31. [Individualized treatment strategies for Clostridium difficile infections].
Solbach P; Dersch P; Bachmann O
Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
[TBL] [Abstract][Full Text] [Related]
32. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland.
Burns K; Morris-Downes M; Fawley WN; Smyth E; Wilcox MH; Fitzpatrick F
J Hosp Infect; 2010 Aug; 75(4):287-91. PubMed ID: 20621236
[TBL] [Abstract][Full Text] [Related]
33. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
Peretz A; Tkhawkho L; Pastukh N; Brodsky D; Halevi CN; Nitzan O
BMC Infect Dis; 2016 Jun; 16():309. PubMed ID: 27334992
[TBL] [Abstract][Full Text] [Related]
34. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
35. Rifaximin in the treatment of recurrent Clostridium difficile infection.
Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
[TBL] [Abstract][Full Text] [Related]
36. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
[TBL] [Abstract][Full Text] [Related]
37. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital.
Goorhuis A; Debast SB; Dutilh JC; van Kinschot CM; Harmanus C; Cannegieter SC; Hagen EC; Kuijper EJ
Clin Infect Dis; 2011 Nov; 53(9):860-9. PubMed ID: 21914851
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
[TBL] [Abstract][Full Text] [Related]
39. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
Li Y; Qian J; Queener E; Shen B
Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Lo Vecchio A; Lancella L; Tagliabue C; De Giacomo C; Garazzino S; Mainetti M; Cursi L; Borali E; De Vita MV; Boccuzzi E; Castellazzi L; Esposito S; Guarino A
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):177-185. PubMed ID: 27696233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
